<DOC>
	<DOCNO>NCT02103998</DOCNO>
	<brief_summary>The investigator hypothesize continuous infusion 4 µg/Kg/day T4 30 µg/Kg/day oral potassium iodide ( KI ) 42 day birth reduce 30 % ( estimate 30 % 21 % ) proportion extremely low gestational age subject composite endpoint `` cerebral palsy ( CP ) Bayley III Composite Cognitive Score &lt; 85 '' 36 month correct postnatal age ( CA ) .</brief_summary>
	<brief_title>Study Thyroid Hormones Prematures</brief_title>
	<detailed_description>This study Phase III multicenter , mask , placebo control randomized clinical trial ( RCT ) thyroid hormone supplementation premature infant . Survival extremely low gestational age neonate ( ELGAN ; 24 - 28 week ) rise &gt; 80 % past 40 year yet cognitive delay cerebral palsy ( CP ) still affect 30 % survivor . Since 25,000 ELGANs born year United States , major priority newborn medicine must translate gain survival gain healthy survival without current high frequency impairment . Transient hypothyroxinemia prematurity ( THOP ) occur 50 % ELGANs strongly associate independent risk factor lower IQ score , behavioral abnormality CP ELGANs . Prior evidence suggest benefit replacement therapy study underpowered prove . The current project extend finding Phase 1 trial ( THOP1 ; R01-NS45109 ) four thyroid hormone regimens test . We show continuous infusion 4 µg/Kg/day thyroxine x 42d could safely correct transient hypothyroxinemia without markedly lower TSH - create `` biochemical euthyroid '' state . THOP2 design test primary hypothesis compare placebo , thyroid hormone supplementation birth reduce 30 % 21 % proportion subject composite endpoint `` CP Bayley III Cognitive Score &lt; 85 . '' A Secondary hypothesis hormone treatment improve measure cognitive executive function attention assess : ) Bayley III Parent Interview Adaptive Behavior BRIEF-P ( Behavioral Rating Inventory Executive Function-Preschool Version ) ii ) frequency screen positive Modified Checklist Autism Toddlers ( M-CHAT ) . We plan enroll 1,224 subject 19.8 month period 14 center obtain 388 survive toddler 36 month correct age two arm . The current application describes scientific basis propose overall clinical trial ; link cluster application create Data Monitoring Analysis Coordinating Center ( DCC ) Michigan State University ( MSU ) . The additional societal cost CP affect person 's lifetime estimate $ 1 million ; cost mental retardation even higher . If trial show inexpensive intervention reduce risk CP mental retardation 30 % ELGANs , estimate overall saving prevent 2,000 case ( 9 % 25,000 ) $ 2 billion per year .</detailed_description>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<criteria>1 . Neonates 24 0/7 27 6/7 week gestational age 2. inborn transfer ; &lt; 24 hour old 1 . Maternal congenital thyroid disease 2 . Maternal substance abuse history time birth ( heroin cocaine ) 3 . Major congenital surgical malformation neonate 4 . Known chromosomal anomaly detect antepartum test direct physical examination 5 . Absence parental consent treat physician assent 6 . A concurrent clinical trial another randomize drug 7 . Death expect &lt; 48h vi ) Another concern treat physician either mandate prohibits study treatment know adverse drug interaction 8. mother &lt; 18 year old delivery</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>24 Hours</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>extremely low gestational age neonate</keyword>
	<keyword>hypothyroxinemia prematurity</keyword>
	<keyword>brain development</keyword>
	<keyword>cerebral palsy</keyword>
	<keyword>cognitive dealy</keyword>
</DOC>